Clinical Implications of the Survival with Oral D-Sotalol (SWORD) Trial: An Investigation of Patients with Left Ventricular Dysfunction after Myocardial Infarction

Cardiac Electrophysiology Review

Volumn 2, Issue 1, 1998, Pages 28-29

  Pratt, Craig M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 2342613673     PISSN: 13852264     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009982121597     Document Type: Article

References (11)

1. Waldo AL, Camm AJ, deRuyter H, Friedman PL, MacNeil DJ, Pitt B, Pratt CM, Rodda BE, Schwartz PJ, for the SWORD investigators. The SWORD trial. Survival with oral d-sotalol in patients with left ventricular dysfunction after myocardial infarction: rationale, design and methods. Am J Cardiol 1995;75:1023-1027.
2. Waldo AL, Camm AJ, deRuyter H, Friedman PL, MacNeil DJ, Pauls JF, Pitt B, Pratt CM, Schwartz PJ, Veltri EP, for the SWORD Investigators. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after myocardial infarction. Lancet 1996;348:7-12.
3. MacNeil DJ, Davies RO, Deitchman D. Clinical safety of sotalol in the treatment of arrhythmias. Am J Cardiol 1993; 72:44A-50A.
4. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989;321:406-412.
5. The Cardiac Arrhythmia Suppression Trial II Investigators. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med 1992;327:227-233.
6. Echt DS, Leibson PR, Mitchell B, Peters RW, Obias-Manno D, Barker AH, Arensberg D, Baker A, Friedman L, Greene HL, Huther ML, Richardson DW, and the CAST investigators. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. N Engl J Med 1991;324: 781-788.
7. Pratt CM. Introduction: the aftermath of the CAST - a reconsideration of traditional concepts. Am J Cardiol 1990; 65:1B-2B.
8. Pratt CM, Moyé LA. The Cardiac Arrhythmia Suppression Trial: background, interim results and implications. Am J Cardiol 1990;65:20B-29B.
9. Beta-Blocker Heart Attack Study Group. The Beta-Blocker Heart Attack Trial. JAMA 246:1981W73-2074.
10. Julian DG, Jackson FS, Prescott RJ, Szekely P. Controlled trial of sotalol for one year after myocardial infarction. Lancet 1982;i:1142-1147.
11. Pratt CM, Greenway PS, Schoenfeld MH, Hibben ML, Reiffel JA. An exploration of the precision of classifying sudden cardiac death: implications for the interpretation of clinical trials. Circulation 1996;93:519-524.